CAPLIN POINT LABORATORIES
|
|
BOM : 524742     NSE : CAPLIPOINT     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward Pledged Shares : None or < 25% |
Mar 20,2023 |
Price(EOD): ₹ 628.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 4,769.94 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
CAPLIN POINT LABORATORIES | -1.7% | -9.2% | -16.2% |
SUN PHARMACEUTICAL INDUSTRIES | 0.4% | -3.5% | 7.8% |
DIVIS LABORATORIES | 1.5% | -2.7% | -36.6% |
CIPLA | -0.6% | -16.3% | -17.2% |
DR REDDYS LABORATORIES | 2.1% | -1.7% | 12.5% |
TORRENT PHARMACEUTICALS | 0.1% | 0.9% | 7.5% |
ABBOTT INDIA | 4.7% | 4.4% | 20.6% |
ZYDUS LIFESCIENCES | 1.1% | -0.3% | 27.1% |
ALKEM LABORATORIES | 0.6% | -6% | -8.9% |
FUNDAMENTAL ANALYSIS OF CAPLIN POINT LABORATORIES
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF CAPLIN POINT LABORATORIES
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
13.38
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 356.56 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] 3.23
P/B Calculated based on Book Value of Rs 1,474.98 Cr
[Latest Year - Mar2022 - Consolidated Results ] 3.37
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,416.69 Cr
[Latest Qtr - Dec2022 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-20% -39% -37% |
SHARE PRICE MOMENTUM OF CAPLIN POINT LABORATORIES
CAPLIN POINT LABORATORIES vs SENSEX
DEBT OF CAPLIN POINT LABORATORIES
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0 0 0 - |
0 0.01 0.04 0.02 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF CAPLIN POINT LABORATORIES
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Dec2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF CAPLIN POINT LABORATORIES
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
3.63% 3.59% 1.15% 5.8% |
14.06% 8.33% 13.25% 22.83% |
QtrlyTrend |
8 | |
Latest Qtr: Dec2022 | ||
Quarterly Result Analysis → |
CAPLIN POINT LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 0.1% | -3.4% | -9.9% |
S&P BSE 500 | -1% | -4.8% | 0.8% |
S&P BSE ALLCAP | -1% | -4.8% | 0.8% |
S&P BSE 250 SMALLCAP | -1.4% | -3.1% | 0.5% |
S&P BSE 400 MIDSMALLCAP | -1.4% | -3.4% | 3.5% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY 500 | -1% | -4.8% | 0.7% |
NIFTY500 MULTICAP 50:25:25 | -1.1% | -4.3% | 0.9% |
NIFTY MID SMALL400 | -1.3% | -3.2% | 3.5% |
NIFTY SMALLCAP250 | -1.6% | -3.8% | -3.2% |
You may also like the below Video Courses
FAQ about CAPLIN POINT LABORATORIES
Is CAPLIN POINT LABORATORIES good for long term investment?
As on Mar 20,2023, the Fundamentals of CAPLIN POINT LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of CAPLIN POINT LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is CAPLIN POINT LABORATORIES UnderValued or OverValued?
As on Mar 20,2023, CAPLIN POINT LABORATORIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of CAPLIN POINT LABORATORIES ?
As on Mar 20,2023, the Intrinsic Value of CAPLIN POINT LABORATORIES is Rs. 992.67 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 781.69
Fair Value [Median EV / Sales Model] : Rs. 1,025.98
Fair Value [Median Price / Sales Model] : Rs. 992.67
Estimated Median Fair Value of CAPLIN POINT LABORATORIES : Rs. 992.67
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.
Is CAPLIN POINT LABORATORIES trading at a Premium or Discount?
As on Mar 20,2023, CAPLIN POINT LABORATORIES is trading at a Discount of -37% based on the estimates of Median Intrinsic Value!